20 November 2026
The ITA reports that a sample collected in-competition on 19 September 2026 during the African Championships in Algiers, Algeria, from Moez Maatoug, a ju-jitsu athlete from Tunisia, has returned an AAF¹ for metablolites of nandrolone.
Nandrolone is listed under section S1.1 “Anabolic Androgenic Steroids” of the WADA Prohibited List. It is a non-specified substance prohibited at all times, both in- and out-of-competition. Nandrolone may be used to boost athletic ability by accelerating recovery and increasing muscle strength and mass.
The athlete has been informed of the case and has the right to request the analysis of the B-sample.
If the B-sample analysis is requested and confirms the result of the A-sample, the case will be considered as a confirmed anti-doping rule violation. If the B-sample analysis is not requested, the case will also go ahead as a confirmed anti-doping rule violation. The athlete will have the opportunity to present his explanations for the result.
Further, in accordance with the World Anti-Doping Code and article 7.4.1 of the JJIF anti-doping rules, a mandatory provisional suspension has been imposed on the athlete. He has the right to challenge the provisional suspension and request its lifting.
Pursuant to JJIF’s delegation of its anti-doping program to the ITA, the prosecution of the case is being handled entirely by the ITA. Given that the case is underway, there will be no further comments made.
¹ A report from a WADA-accredited laboratory that, consistent with the International Standard for Laboratories, establishes in a sample the presence of a prohibited substance or its metabolites or markers or evidence of the use of a prohibited method.